Medical marijuana, also known as cannabis, has been used for centuries to treat a variety of medical conditions. More recently, it has been studied for its potential benefits in treating symptoms of multiple sclerosis (MS). MS is a chronic, progressive disease of the central nervous system that affects the brain and spinal cord. It is characterized by symptoms such as muscle spasticity, pain, and fatigue.

​

The active compounds in medical marijuana, known as cannabinoids, have been found to have anti-inflammatory and analgesic properties. These properties make it a potential treatment option for the management of symptoms of MS. The two main cannabinoids found in medical marijuana are tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the psychoactive compound that is responsible for the "high" associated with marijuana use, while CBD does not have psychoactive effects.

​

Studies have shown that medical marijuana can be effective in reducing muscle spasticity and pain in individuals with MS. In a randomized, double-blind, placebo-controlled study, patients with MS who received oral THC experienced a significant reduction in muscle spasticity compared to those who received a placebo. Another study found that a combination of THC and CBD was effective in reducing pain and spasticity in individuals with MS.

​

Medical marijuana has also been found to have potential benefits in treating other symptoms of MS such as fatigue and sleep disturbances. A survey of individuals with MS found that those who used medical marijuana reported an improvement in fatigue and sleep quality.

​

In addition to its potential benefits, medical marijuana also has some potential risks and side effects. These include dizziness, drowsiness, and dry mouth. It is also important to note that marijuana is still classified as a Schedule I drug by the federal government, which means it is illegal to use, possess or distribute it. However, many states in the United States have legalized the use of medical marijuana for certain medical conditions.

​

In conclusion, medical marijuana has been found to be an effective treatment option for reducing muscle spasticity, pain, and fatigue in individuals with MS. Further research is needed to fully understand the potential benefits and risks of using medical marijuana in the treatment of MS. However, many states have legalized medical marijuana, which provides an option for patients suffering from MS to use it as a therapy option.